Learning From China’s Experience Fighting Coronavirus
As Covid-19 disease reaches more countries and new reported cases continue to rise, public anxiety will increase and add more uncertainty for investors. Beyond efforts to contain the outbreak, we expect countries to intensify their fight against this highly contagious disease. We think significant insights can be gained by studying China’s experience in combating Covid-19.
The outbreak first started in China in December 2019. Following the government’s decisive actions, available data suggest that the coronavirus has now been largely contained. The economic and social costs of these measures are unfolding, but the actions have been effective.
Some observations from China’s experience with Covid-19 are:
Epidemic curve in China indicates successful containment
Commitment to contain the virus was directed by the highest level of leadership, which mobilized all available resources
Draconian actions, such as factory closures and mandatory quarantines, were taken at high costs
Fatality rates outside the Hubei Province are materially lower than inside it
China has provided measured, targeted stimulus as well as rate cuts to cushion the impact on small-and-medium enterprises and households; more stimulus measures are expected
Economy is coming back to life, gradually, as evidenced in various high frequency measures of economic activity
Key ongoing challenges for China are:
Containing imported cases
Preventing a flareup of virus cases as normal daily life returns
Implementing sufficient fiscal and monetary stimulus to ensure economic growth recovers, while at the same time not creating excessive and/or inefficient credit growth
Profound changes in consumer and business behaviors taking place during the outbreak may have lasting consequences. Social distancing has become a key operative word in the time of Covid-19, driving accelerated adoption of e-commerce, telecommuting and online entertainment. Also, the virus has increased awareness of the need for preventative health care as well as health and life insurance. The short-term negative impact on the global economy and capital markets could be significant. To eventually win this war, we need an effective treatment for and vaccine against the Covid-19 and this may take some time.
From an investment viewpoint, China looks to be in a better spot compared with most other countries. As the first country going into the war against Covid-19, China has managed through the initial surge phase of the outbreak and containment now looks achievable. The Chinese economy has taken a huge hit, but high-frequency economic activity data to date, such as coal consumption, suggests there is a gradual yet steady recovery in economic activity as the outbreak is contained.
In contrast, most other large economies are just beginning to recognize and take on the tough fight against Covid-19. The transient nature of the virus’ economic impact along with expectations of continued policy support may also be contributing to China’s outperformance in the MSCI Emerging Markets benchmark.
As active fundamental emerging market investors, we believe that excess returns above that of passive index can be achieved through a disciplined investment process that aims to identify long-term winners among all the listed companies.
There will be winners and losers among sectors and industries in the war against Covid-19. Among the losers we see travel & leisure, transportation and energy. Among winners are e-commerce, online entertainment and health care. Higher-quality companies with more resilient business models and stronger financial positions will likely emerge from this crisis in a better position to deliver returns for shareholders.
Before investing, consider the funds' investment objectives, risks, charges and expenses. To obtain a prospectus or summary prospectus which contains this and other information, call 1-800-997-7327, download a prospectus or summary prospectus now, or talk to your financial advisor. Read it carefully before investing.
Distributor: State Street Global Advisors Funds Distributors, LLC, member FINRA, SIPC, an indirect wholly owned subsidiary of State Street Corporation. References to State Street may include State Street Corporation and its affiliates. Certain State Street affiliates provide services and receive fees from the SSGA Funds.
THIS SITE IS INTENDED FOR U.S. INVESTORS ONLY.
No Offer/Local Restrictions
Nothing contained in or on the Site should be construed as a solicitation of an offer to buy or offer, or recommendation, to acquire or dispose of any security, commodity, investment or to engage in any other transaction. SSGA Intermediary Business offers a number of products and services designed specifically for various categories of investors. Not all products will be available to all investors. The information provided on the Site is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation.
All persons and entities accessing the Site do so on their own initiative and are responsible for compliance with applicable local laws and regulations. The Site is not directed to any person in any jurisdiction where the publication or availability of the Site is prohibited, by reason of that person's nationality, residence or otherwise. Persons under these restrictions must not access the Site.
Information for Non-U.S. Investors:
The products and services described on this web site are intended to be made available only to persons in the United States, and the information on this web site is only for such persons. Nothing on this web site shall be considered a solicitation to buy or an offer to sell a security to any person in any jurisdiction where such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction.